Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients

Adj PD-1 did not improve the prognosis in sole AM. However, further studies are essential to evaluate the efficacy of the adj anti-PD-1 antibody in AM.

Authors

Institutions

Publication Details

Journal
JCO Global Oncology
Published
2025-04-01
DOI
https://doi.org/10.1200/go-24-00644
Citations
6
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
6.27
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients

Hiraku Kokubu, Naoya Yamazaki, Jun Asai, Hiroshi Uchi et al.
6 citations
JCO Global Oncology
Cutaneous Melanoma Detection and Management
6.27
article

Adjuvant Anti–PD-1 Monotherapy Versus Observation for Stage III Acral Melanoma of the Sole: A Multicenter Retrospective Study in Japanese Patients

Hiraku Kokubu, Naoya Yamazaki, Jun Asai, Hiroshi Uchi, Yosuke Yamamoto, Akiko Kishi, Satoshi Fukushima, Takafumi Kadono, Yoshiyasu Umeda, Reiichi Doi, Shigeto Matsushita, Yukiko Kiniwa, Nobuo Kanazawa, Keiko Manabe, Takeo Maekawa, Naohito Hatta, Takuya Miyagawa, Takeru Funakoshi, Azusa Hiura, Takashi Inozume, Takamichi Ito, Hisashi Uhara, Eiji Nakano, Masahiro Nakagawa, Takahiro Haga, Yuki Ichigozaki, Shigeru Koizumi, Kenta Nakama, Tatsuya Takenouchi, Shoichiro Ishizuki, Yuki Yamamoto, Dai Ogata, Tomoe Nakagawa, Yutaka Kuwatsuka, Toshihiro Takai, Masahito Yasuda, Shiro Iino, K. Inafuku, Takahide Kaneko, Toshihiko Hoashi, Yasuhiro Nakamura, Sayuri Sato, Shoichiro Minami, Hiroshi Kitagawa, Masashi Ishikawa, Hideki Kamiya, Masaru Arima, Utsugi Iwasawa, Kenji Asagoe, Shusaku Ito
article en
6 citations

Abstract

Adj PD-1 did not improve the prognosis in sole AM. However, further studies are essential to evaluate the efficacy of the adj anti-PD-1 antibody in AM.

JCO Global OncologyVol. 11(11)
Kurume University (JP), University of Fukui (JP), Kyushu University (JP), Shinshu University (JP), Sapporo Medical University (JP), Fujita Health University (JP), University of Tsukuba (JP), Jichi Medical University (JP), Asahikawa Medical University (JP), Chiba University (JP), Shiga University of Medical Science (JP), St. Marianna University School of Medicine (JP), Gunma University (JP), Mie University (JP), Kawasaki Medical School (JP), Wakayama Medical University (JP), Keio University (JP), Hamamatsu University School of Medicine (JP), Kyoto Prefectural University of Medicine (JP), Toyama Prefectural Central Hospital (JP), Niigata Cancer Center Hospital (JP), National Hospital Organization Kyushu Cancer Center (JP), Takamatsu Red Cross Hospital (JP), Kisarazu Hospital (JP), Tokyo Metropolitan Hiroo Hospital (JP), Saitama Cancer Center (JP), Itami City Hospital (JP), Saitama International Medical Center (JP), Juntendo University Urayasu Hospital (JP), Kagoshima Medical Center (JP), Hitachi General Hospital (JP), Okayama Medical Center (JP), Nippon Medical School Hospital (JP), Ōtani University (JP), Hyogo Prefectural Cancer Center (JP), Nagasaki University Hospital (JP), Jichi Medical University Saitama Medical Center (JP), Toranomon Hospital (JP), The University of Tokyo (JP), Hyogo University (JP), Saitama Medical University (JP), Teikyo University (JP), Kumamoto University (JP)
Good health and well-being
Openalex Percentile: Top 3%
Cutaneous Melanoma Detection and Management
6.27
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.